Key regions: Canada, United States, Australia, Brazil, Japan
The Digestives & Intestinal Remedies market in NAFTA is experiencing significant growth and development due to several key factors.
Customer preferences: Customers in the NAFTA region are increasingly seeking natural and organic remedies for digestive and intestinal issues. This preference for natural products is driven by a growing awareness of the potential side effects of traditional pharmaceuticals and a desire for more holistic approaches to health and wellness. Additionally, consumers are becoming more proactive in managing their digestive health, leading to an increased demand for over-the-counter remedies that can be easily accessed and used without a prescription.
Trends in the market: One of the major trends in the Digestives & Intestinal Remedies market in NAFTA is the rise of probiotics. Probiotics are live bacteria and yeasts that are beneficial to digestive health. They are found in certain foods and supplements, and their popularity has surged in recent years. Probiotics are believed to restore the natural balance of bacteria in the gut and improve digestion. This trend is driven by increasing consumer awareness of gut health and the role of probiotics in maintaining a healthy digestive system.Another trend in the market is the growing popularity of herbal remedies. Many consumers are turning to herbal remedies such as peppermint oil, ginger, and chamomile to alleviate digestive issues. These natural remedies are perceived as safer and gentler alternatives to traditional pharmaceuticals, and they often have fewer side effects. The demand for herbal remedies is also driven by the growing interest in traditional and alternative medicine.
Local special circumstances: Within the NAFTA region, there are some local special circumstances that are influencing the development of the Digestives & Intestinal Remedies market. For example, in the United States, there is a strong emphasis on self-care and self-medication. Consumers in the U.S. are more likely to try over-the-counter remedies before seeking medical advice. This has led to a higher demand for accessible and affordable digestive remedies that can be purchased without a prescription.Another local special circumstance is the aging population in Canada. As the baby boomer generation enters retirement age, there is a growing demand for digestive remedies to address age-related digestive issues. This has created opportunities for companies to develop products specifically targeted towards the elderly population.
Underlying macroeconomic factors: The growth of the Digestives & Intestinal Remedies market in NAFTA is also influenced by underlying macroeconomic factors. For example, the increasing prevalence of digestive disorders such as irritable bowel syndrome and acid reflux is driving the demand for digestive remedies. These conditions are often associated with stress, poor diet, and sedentary lifestyles, which are common in developed countries like the United States, Canada, and Mexico.Additionally, the rising healthcare costs in the region are leading consumers to seek more cost-effective solutions for managing their digestive health. Over-the-counter remedies are often more affordable than prescription medications and can be easily purchased without the need for a doctor's visit. This affordability and accessibility are contributing to the growth of the Digestives & Intestinal Remedies market in NAFTA.In conclusion, the Digestives & Intestinal Remedies market in NAFTA is experiencing growth and development due to customer preferences for natural and organic remedies, trends such as the rise of probiotics and herbal remedies, local special circumstances such as the emphasis on self-care in the U.S. and the aging population in Canada, and underlying macroeconomic factors including the increasing prevalence of digestive disorders and rising healthcare costs.
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
